Brokers bullish on SBI, Cairn India, Glaxo Pharma

Published on Fri, Oct 31, 2008 at 11:11 |  Source : Moneycontrol.com

Updated at Fri, Oct 31, 2008 at 11:13  

160039 Investors following SBI. Share this News with them.
0
0
Share on Tumblr

Other Stocks in this news

Cairn India | GlaxoSmithKline Pharmaceuticals |

Goldman Sachs has kept sell rating on ONGC, with price target Rs 625

Sharekhan has kept buy rating on SBI, with price target Rs 1801

CLSA has kept buy rating on SBI, with price target Rs 1650

CLSA has kept buy rating on Cairn India, with price target Rs 290

Motilal Oswal Sec has kept buy rating on Glaxo Pharma, with price target Rs 1392

Motilal Oswal Sec has kept buy rating on ICICI Bank, with price target Rs 581

Kotak Institution has kept reduce on NTPC, with price target Rs 160

Kotak Institution has upgraded SBI to buy rating, with price target Rs 1600

Kotak Institution has kept buy rating on Tata Power, with price target Rs 1275

Emkay has kept buy rating on Bank Of India, with price target Rs 340

Citi has kept sell rating on Tata Tele, with price target Rs 12

Citi has kept buy rating on M&M, with price target Rs 447

House

Stocks

Views

Goldman Sachs

ONGC

Sell; with price target Rs 625

Sharekhan

SBI

Buy; with price target Rs 1801

CLSA

SBI

 

 

Cairn India

Buy; with price target Rs 1650

 

Buy; with price target Rs 290

Motilal Oswal Sec

Glaxo Pharma

 

 

ICICI Bank

Buy; with price target Rs 1392

 

Buy; with price target Rs 581

Kotak Institution

NTPC

 

 

SBI

 

 

Tata Power

Reduce; with price target Rs 160

 

Buy; with price target Rs 1600

 

Buy; with price target Rs 1275

 

Emkay

Bank Of India

Buy; with price target Rs 340

Citi

Tata Tele

 

 

M&M

Sell; with price target Rs 12

 

Buy; with price target Rs 447

  

Trending News

Business News

Google's Project Glass taken for a spin, 720p video recording showcased
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!